Court Finds Defendant’s Valuation Had ‘Mixed Purpose’ and Orders Disclosure

BVLaw
Court Case Digests
November 9, 2018
2834 Pharmaceutical Preparations
325412 Pharmaceutical Preparation Manufacturing
discovery
discovery, work-product doctrine, relevant, valuation report, attorney-client privilege

Noven Pharmaceuticals v Novartis Pharmaceuticals
2018 N.Y. Mis. LEXIS 5133
US
State Court
New York
Supreme Court of New York (Trial Court)
N/A (plaintiff); N/A (defendant)
Schecter

Summary

In breach of contract action, court finds defendant’s valuation report is discoverable; report is relevant to an issue in dispute and not protected by attorney-client privilege or work-product doctrine where valuation was not done solely in anticipation of litigation but had mixed purpose.

See Also

Noven Pharmaceuticals v Novartis Pharmaceuticals

In breach of contract action, court finds defendant’s valuation report is discoverable; report is relevant to an issue in dispute and not protected by attorney-client privilege or work-product doctrine where valuation was not done solely in anticipation of litigation but had mixed purpose.